ARL4C: A Drug Target / Disease Biomarker (G10123)

Target Name: ARL4C

NCBI ID: G10123

ARL4C

ARL4C: A Drug Target / Disease Biomarker

ARL4C, also known as ARL4, is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the ARL4 family of proteins, which are known for their role in cell signaling and development.

One of the key functions of ARL4C is its role in cell signaling. ARL4C is a component of the T-cell receptor, which is a critical signaling pathway that helps coordinate the immune response to the presence of foreign substances in the body. ARL4C plays a role in the regulation of the T-cell receptor, allowing it to be activated and help stimulate an immune response.

In addition to its role in cell signaling, ARL4C is also involved in the regulation of cell growth and differentiation. It has been shown to play a role in the regulation of the stem cell, and has been shown to help control the growth and differentiation of stem cells into different types of cells in the body.

As a drug target, ARL4C is being targeted by researchers to investigate its potential as a new treatment for various diseases. One of the main reasons for its potential as a drug is its ability to stimulate an immune response, which makes it a strong candidate for vaccines and other treatments that stimulate the immune system.

In addition to its potential as an immune system trigger, ARL4C is also being investigated for its potential as a cancer treatment. Its ability to regulate cell growth and differentiation makes it a potential target for cancer treatments that want to inhibit the development and progression of cancer cells.

Overall, ARL4C is a protein that is being actively investigated as a potential drug target due to its role in cell signaling and its potential as a cancer treatment. With further research, it is possible that ARL4C will be shown to be an effective and safe treatment for a variety of diseases.

Protein Name: ADP Ribosylation Factor Like GTPase 4C

Functions: Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. May be involved in transport between a perinuclear compartment and the plasma membrane, apparently linked to the ABCA1-mediated cholesterol secretion pathway. Recruits CYTH1, CYTH2, CYTH3 and CYTH4 to the plasma membrane in the GDP-bound form. Regulates the microtubule-dependent intracellular vesicular transport from early endosome to recycling endosome process

The "ARL4C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARL4C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets